Prime editing of the β1 adrenoceptor in the brain restores physiological REM sleep in a mouse model of Alzheimer’s disease

Prime editing offers versatile genome modifications with therapeutic potential; yet its use to modulate neural circuitry remains underexplored. Here, we used adeno-associated viral vectors to deliver prime editors into the mouse brain and introduced the naturally occurring Adrb1<sup>A187V</sup> variant of the β1-adrenergic receptor, linked to short sleep in humans and mice. Editing reached up to 28.1% in the cortex six months after intracerebroventricular injection and increased excitability of β1-noradrenergic neurons. This enhanced wake-associated behaviors, including home cage activity, locomotion, exploration, and recognition memory, while reducing slow wave activity (SWA) during non-rapid eye movement (NREM) sleep indicating reduced build-up of sleep pressure during active phases. In a mouse model of Alzheimer's disease, Adrb1<sup>A187V</sup> installation restored physiological REM sleep and again reduced NREM sleep SWA following spontaneous activity. Together, these findings demonstrate the feasibility of prime editing for reprogramming genetic circuits in the brain and reveal beneficial effects of the Adrb1<sup>A187V</sup> variant on activity and sleep regulation.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-12-09
DOI
https://doi.org/10.1038/s41467-025-65964-w
Primary Topic
Neurobiology and Insect Physiology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prime editing of the β1 adrenoceptor in the brain restores physiological REM sleep in a mouse model of Alzheimer’s disease

Jonas Mumenthaler, Romain Goutagny, Gerald Schwank, Sian N. Duss et al.
Nature Communications
Neurobiology and Insect Physiology Research
article

Prime editing of the β1 adrenoceptor in the brain restores physiological REM sleep in a mouse model of Alzheimer’s disease

Jonas Mumenthaler, Romain Goutagny, Gerald Schwank, Sian N. Duss, Adriano Aguzzi, Maria Wilhelm, Athena Economides, Lukas Schmidheini, Raquel Mendes, Johannes Bohacek, Sharan Janjuha, Jochen Winterer, Tanja Rothgangl, Anna Maria Reuss, Chiara Trevisan, Tommaso Patriarchi, Konstantinos Kompotis, Yanik Weber, Mattia Privitera, Lucas Kissling, Yaroslav Sych, Matteo Ranucci, Lisa Tidecks, Waleed ElGrawani, Dalila Laura Vena, Elina Andrea Villiger, Eleonora I. Ioannidi, Chantal Mathis, Desirée Böck, Lisa K. Polzer, Justine Leonardi
article en

Abstract

Prime editing offers versatile genome modifications with therapeutic potential; yet its use to modulate neural circuitry remains underexplored. Here, we used adeno-associated viral vectors to deliver prime editors into the mouse brain and introduced the naturally occurring Adrb1<sup>A187V</sup> variant of the β1-adrenergic receptor, linked to short sleep in humans and mice. Editing reached up to 28.1% in the cortex six months after intracerebroventricular injection and increased excitability of β1-noradrenergic neurons. This enhanced wake-associated behaviors, including home cage activity, locomotion, exploration, and recognition memory, while reducing slow wave activity (SWA) during non-rapid eye movement (NREM) sleep indicating reduced build-up of sleep pressure during active phases. In a mouse model of Alzheimer's disease, Adrb1<sup>A187V</sup> installation restored physiological REM sleep and again reduced NREM sleep SWA following spontaneous activity. Together, these findings demonstrate the feasibility of prime editing for reprogramming genetic circuits in the brain and reveal beneficial effects of the Adrb1<sup>A187V</sup> variant on activity and sleep regulation.

Nature CommunicationsVol. 16(1)
Centre National de la Recherche Scientifique (FR), University of Zurich (CH), ETH Zurich (CH), Institut des Neurosciences Cellulaires et Intégratives (FR), Université de Strasbourg (FR), Freie Universität Berlin (DE)
National Science Foundation, Michael J. Fox Foundation for Parkinson's Research, Alzheimer's Association, Novartis Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Eidgenössische Technische Hochschule Zürich, Université de Strasbourg, Novartis Stiftung für Medizinisch-Biologische Forschung, Centre National de la Recherche Scientifique, Universität Zürich, Helmut Horten Stiftung, Foundation for Research in Science and the Humanities
Openalex Percentile: Top 58%
Neurobiology and Insect Physiology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.